S.08.06 MDMA-assisted psychotherapy for PTSD: A promising novel experimental treatment moving into phase 3 trials with FDA breakthrough therapy designation. - Mithoefer, M.; Mithoefer, A.; Feduccia, A.; Jerome, I.; Wagner, M.; Hoilland, J.; Hamilton, S.; Yazar-Klosinski, B.; Emerson, A.; Doblin, R. (European Neuropsychopharmacology, 2019)